Sumit Majumdar, Ph.D.
Affiliations: | 2008 | Pharmaceutical Chemistry | University of Kansas, Lawrence, KS, United States |
Area:
Pharmaceutical ChemistryGoogle:
"Sumit Majumdar"Mean distance: (not calculated yet)
Parents
Sign in to add mentorTeruna J. Siahaan | grad student | 2008 | University of Kansas | |
(Targeted drug delivery to leukocytes with ICAM -1 derived peptides.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Majumdar S, Anderson ME, Xu CR, et al. (2012) Methotrexate (MTX)-cIBR conjugate for targeting MTX to leukocytes: conjugate stability and in vivo efficacy in suppressing rheumatoid arthritis. Journal of Pharmaceutical Sciences. 101: 3275-91 |
Majumdar S, Siahaan TJ. (2012) Peptide-mediated targeted drug delivery. Medicinal Research Reviews. 32: 637-58 |
Majumdar S, Tejo BA, Badawi AH, et al. (2009) Effect of modification of the physicochemical properties of ICAM-1-derived peptides on internalization and intracellular distribution in the human leukemic cell line HL-60. Molecular Pharmaceutics. 6: 396-406 |
Zimmerman T, Oyarzabal J, Sebastián ES, et al. (2007) ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization. Chemical Biology & Drug Design. 70: 347-53 |
Majumdar S, Kobayashi N, Krise JP, et al. (2007) Mechanism of internalization of an ICAM-1-derived peptide by human leukemic cell line HL-60: influence of physicochemical properties on targeted drug delivery. Molecular Pharmaceutics. 4: 749-58 |
Dunehoo AL, Anderson M, Majumdar S, et al. (2006) Cell adhesion molecules for targeted drug delivery. Journal of Pharmaceutical Sciences. 95: 1856-72 |
Kobayashi N, Ikesue A, Majumdar S, et al. (2006) Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion. The Journal of Pharmacology and Experimental Therapeutics. 317: 309-16 |